← 產業報告目錄
Radiopharmaceutical Preclinical CRO Market Size, Share & Trends Analysis Distribution by Organization Size (Small & Medium Enterprises (SMEs), Large Pharmaceutical Corporations), Radiopharmaceutical Types (PET Tracers, SPECT Tracers, Therapeutic Radiopharmaceuticals), Services, Therapeutic Area, End-Users and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-10頁數 170報告編號 INSIGHTACE-f79d45d4ac
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
A CAGR of 8.5% is forecasted for the global Radiopharmaceutical Preclinical CRO Market over the assessment period of 2025 through 2034.
At its core, Radiopharmaceutical Preclinical CRO pertains to The radiopharmaceutical preclinical CRO market represents a vital part of the healthcare and pharmaceutical industry, dedicated to the development and testing of radiopharmaceutical drugs. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Radiopharmaceutical Preclinical CRO Market Snapshot
Chapter 4. Global Radiopharmaceutical Preclinical CRO Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. End-Users Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Organization Size Estimates & Trend Analysis
5.1. By Organization Size & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Organization Size:
5.2.1. Small and Medium Enterprises (SMEs)
5.2.2. Large Pharmaceutical Corporations
Chapter 6. Market Segmentation 2: By Radiopharmaceutical Types Estimates & Trend Analysis
6.1. By Radiopharmaceutical Types & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Radiopharmaceutical Types:
6.2.1. PET Tracers
6.2.2. SPECT Tracers
6.2.3. Therapeutic Radiopharmaceuticals
Chapter 7. Market Segmentation 3: By Services Estimates & Trend Analysis
7.1. By Services & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Services:
7.2.1. Safety Assessment
7.2.2. Bioanalytical Testing
7.2.3. Dose Formulation
7.2.4. Regulatory Affairs Support
Chapter 8. Market Segmentation 4: By Therapeutic Area Estimates & Trend Analysis
8.1. By Therapeutic Area & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Area:
8.2.1. Oncology
8.2.2. Cardiology
8.2.3. Neurology
8.2.4. Other Therapeutic Area
Chapter 9. Market Segmentation 5: By End-Users Estimates & Trend Analysis
9.1. By End-Users & Market Share, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users:
9.2.1. Pharmaceutical Companies
9.2.2. Biotechnology Firms
9.2.3. Academic Research Institutions
9.2.4. Government Organizations
Chapter 10. Radiopharmaceutical Preclinical CRO Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Organization Size, 2021-2034
10.1.2. North America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Radiopharmaceutical Types, 2021-2034
10.1.3. North America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Services, 2021-2034
10.1.4. North America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
10.1.5. North America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034
10.1.6. North America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) By Organization Size, 2021-2034
10.2.2. Europe Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) By Radiopharmaceutical Types, 2021-2034
10.2.3. Europe Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Services, 2021-2034
10.2.4. Europe Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
10.2.5. Europe Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034
10.2.6. Europe Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) By Organization Size, 2021-2034
10.3.2. Asia Pacific Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) By Radiopharmaceutical Types, 2021-2034
10.3.3. Asia Pacific Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Services, 2021-2034
10.3.4. Asia Pacific Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
10.3.5. Asia Pacific Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034
10.3.6. Asia Pacific Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) By Organization Size, (US$ Million) 2021-2034
10.4.2. Latin America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) By Radiopharmaceutical Types, (US$ Million) 2021-2034
10.4.3. Latin America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Services, 2021-2034
10.4.4. Latin America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
10.4.5. Latin America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034
10.4.6. Latin America Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) By Organization Size, (US$ Million) 2021-2034
10.5.2. Middle East & Africa Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) By Radiopharmaceutical Types, (US$ Million) 2021-2034
10.5.3. Middle East & Africa Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Services, 2021-2034
10.5.4. Middle East & Africa Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
10.5.5. Middle East & Africa Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034
10.5.6. Middle East & Africa Radiopharmaceutical Preclinical CRO Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Charles River Laboratories International, Inc.
11.2.2. Pharmaron Beijing Co., Ltd.
11.2.3. Bioscan, Inc.
11.2.4. Invicro (Konica Minolta)
11.2.5. PerkinElmer, Inc.
11.2.6. Siemens Healthineers
11.2.7. IBA Radiopharma Solutions
11.2.8. Covance, Inc. (Labcorp Drug Development)
11.2.9. NorthStar Medical Radioisotopes, LLC
11.2.10. PAREXEL International Corporation
11.2.11. Eckert & Ziegler
11.2.12. Jubilant Radiopharma
11.2.13. Cardinal Health, Inc.
11.2.14. Curium Pharma
11.2.15. ImaginAb, Inc.
11.2.16. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們